This patent teaches how to make liver cells behave like pancreatic cells and even offers the possibility of treating type 1 diabetes. Essentially the patent claims that by transfecting liver cells with the pancreatic stem cell transcription factor PDX-1, the liver cells will start producing insulin (besides other things).
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.